Evidence map›Paper›PMID 23483368›Full record

ReviewCNS drugs2013

Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.

Christopher R Bailey, Elisabeth Cordell, Sean M Sobin, Alexander Neumeister

Registry-linked trialAbstract readReview
In one paragraph

Review in CNS drugs, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03752918 (The Effects of MDMA on Prefrontal and Amygdala Activation in Posttraumatic Stress Disorder), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03752918 phase1withdrawnnot on this mapstarted 2024, after this paper: background citation

The Effects of MDMA on Prefrontal and Amygdala Activation in Posttraumatic Stress Disorder

TypeinterventionalSponsorYale UniversityRan2024 to 2028Enrolled0ConditionsPost Traumatic Stress DisorderArmsMDMA, Niacin
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Investigational drugs in PTSD.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. The effect of obstructive sleep apnea severity on PTSD symptoms during the course of esketamine treatment: a retrospective clinical study.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
  10. Article
  11. Emphasizing the Crosstalk Between Inflammatory and Neural Signaling in Post-traumatic Stress Disorder (PTSD).Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Review
  12. Review
  13. Article
  14. Iranian journal of basic medical sciences · 2021
    Article
  15. Article
  16. Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  17. Elucidating Mental Health Disorders among Rohingya Refugees: A Malaysian Perspective.International journal of environmental research and public health · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christopher R BaileyJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Elisabeth Cordell
Sean M Sobin
Alexander Neumeister

Funding

CB1 Receptor PET Imaging Reveals Gender Differencesin PTSDR01MH096876 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NEUMEISTER, ALEXANDER · 2012 to 2014
$921k
Kappa Opioid Receptor Imaging in PTSDR21MH096105 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NEUMEISTER, ALEXANDER · 2012 to 2014
$746k
Serotonin 1B Receptor Imaging in Major Depressive DisorderR21MH081103 · NIMH · YALE UNIVERSITY · PI NEUMEISTER, ALEXANDER · 2009 to 2010
$413k
Serotonin 1B Receptor Imaging in PTSD with and without Co-morbid DepressionR21MH085627 · NIMH · YALE UNIVERSITY · PI NEUMEISTER, ALEXANDER · 2009 to 2010
$411k
NIMH NIH HHS R01 MH096876NIMH NIH HHS R01 MH096876-01A1NIMH NIH HHS R21 MH081103NIMH NIH HHS R21 MH085627NIMH NIH HHS R21 MH096105NIMH NIH HHS R21 MH096105-01A1
6 · The paper itself

Abstract

Post-traumatic stress disorder (PTSD) is a common and chronic anxiety disorder that can result after exposure to a traumatic event. Though our understanding of the aetiology of PTSD is incomplete, several neurobiological systems have been implicated in the pathophysiology and vulnerability towards developing PTSD after trauma exposure. We aimed to provide a concise review of benchmark findings in important neurobiological systems related to the aetiology and maintenance of PTSD symptomology. Specifically, we discuss functional aetiologies in the noradrenergic, serotonergic, endogenous cannabinoid and opioid systems as well as the hypothalamic-pituitary adrenal (HPA) axis. This article provides a succinct framework to appreciate the current understanding of neurobiological mechanisms related to the pathophysiology of PTSD and how these findings may impact the development of future, targeted pharmacological treatments for this debilitating disorder.

Indexed as

Drug DesignMolecular Targeted TherapyAnimalsFemaleHumansHypothalamo-Hypophyseal SystemMalePituitary-Adrenal SystemStress Disorders, Post-Traumatic

Identifiers

PMID23483368
PMCPMC3629370

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.